Features of Hypertension in Diabetes Based on Activity Lowering of 11.BETA. - Hydroxysteroid Dehydrogenase.

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.28.189
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

Increased 11[beta]-Hydroxysteroid Dehydrogenase Type 1 Activity in UVB-irradiated Mice

Endocrine Abstracts
2014English

11?-Hydroxysteroid Dehydrogenase Type 1 in Obesity and Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Stabilization of 20.beta.-Hydroxysteroid Dehydrogenase by Glycerol.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1980English

Role of 11 -Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries

Hypertension
Internal Medicine
2000English

11 -Hydroxysteroid Dehydrogenase Deficit: A Rare Cause of Arterial Hypertension. Diagnosis and Therapeutic Approach in Two Young Brothers

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1996English

Interactions Between 11 -Hydroxysteroid Dehydrogenase and COX-2 in Kidney

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2005English

20.alpha.-Hydroxysteroid Dehydrogenase Activity in Rat Placenta.

Endocrine Journal
EndocrinologyMetabolismDiabetes
1993English

Mild Adrenal 3.beta.-Hydroxysteroid Dehydrogenase Deficiency With Hyperaldosteronism.

Endocrinologia Japonica
1988English

Mutants of 11 -Hydroxysteroid Dehydrogenase (11-Hsd2) With Partial Activity : Improved Correlations Between Genotype and Biochemical Phenotype in Apparent Mineralocorticoid Excess

Hypertension
Internal Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy